NCT01856556View on ClinicalTrials.gov

Safety and Pharmacokinetics of NRX-1074 in Normal Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Healthy
Interventions
DRUG

NRX-1074

Single IV or PO administration

DRUG

Placebo

Single IV or PO placebo administration

Trial Locations (1)

91105

Lotus Clinical Research, Pasadena

All Listed Sponsors
lead

Naurex, Inc, an affiliate of Allergan plc

INDUSTRY

NCT01856556 - Safety and Pharmacokinetics of NRX-1074 in Normal Volunteers | Biotech Hunter | Biotech Hunter